Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000108

Options or other derivatives

  • SVP, GEN COUNSEL & CORP SEC acquired 26,125 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2024-11-07 Grant or award · Performance Stock Option (right to buy) +26,125 26,125 D
Loading xslF345X05/wk-form4_1731117010.xml…